secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2026-01-26T23:59:59+00:00
Accession:  0001437749-26-002078
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics secures up to $1.6M loan with 10%-12% PIK interest paid in warrants; insider participation
--------------------------------------------------------------------------------

- Loan agreement for $1.0M initial + $600K second tranche (Sept 30, 2026); $1.0M funded Jan 23, 2026.
- Interest 10% annual on initial note, rising to 12% if second tranche is taken; accrued interest paid only in warrants at maturity.
- Principal repaid in 8 equal quarterly installments from Mar 31, 2027 to Dec 31, 2028; early prepayment fee 1.5-2.75% of principal paid in warrants.
- Lenders include director/10% owner Scott Pittman ($200K) and >5% owner Paul Jacobs ($300K); each received initial and potential second warrants.
- Warrants exercisable at $1.50/share, expiring Jan 23, 2031; up to 226,000 interest warrant shares issuable at maximum borrowing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774926002078/0001437749-26-002078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774926002078/aurx20260122_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-002078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer